Your browser is no longer supported. Please, upgrade your browser.
Settings
PEN Penumbra, Inc. daily Stock Chart
PEN [NYSE]
Penumbra, Inc.
Index- P/E403.74 EPS (ttm)0.36 Insider Own1.90% Shs Outstand34.80M Perf Week-2.67%
Market Cap5.03B Forward P/E130.92 EPS next Y1.10 Insider Trans-17.67% Shs Float32.60M Perf Month-18.46%
Income15.00M PEG20.19 EPS next Q0.17 Inst Own87.70% Short Float13.08% Perf Quarter5.27%
Sales495.20M P/S10.16 EPS this Y-70.90% Inst Trans-0.43% Short Ratio11.17 Perf Half Y-1.22%
Book/sh13.09 P/B11.04 EPS next Y34.63% ROA2.80% Target Price174.33 Perf Year15.63%
Cash/sh5.38 P/C26.86 EPS next 5Y20.00% ROE3.50% 52W Range110.84 - 185.70 Perf YTD18.28%
Dividend- P/FCF708.45 EPS past 5Y44.10% ROI0.90% 52W High-22.16% Beta0.77
Dividend %- Quick Ratio4.30 Sales past 5Y38.00% Gross Margin66.90% 52W Low30.40% ATR5.91
Employees2200 Current Ratio6.20 Sales Q/Q22.40% Oper. Margin2.00% RSI (14)35.09 Volatility2.49% 3.67%
OptionableYes Debt/Eq0.00 EPS Q/Q23.60% Profit Margin3.00% Rel Volume0.69 Prev Close144.54
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout0.00% Avg Volume381.82K Price144.54
Recom1.60 SMA20-8.51% SMA50-11.74% SMA200-0.29% Volume0 Change0.00%
Jun-13-19Reiterated BofA/Merrill Buy $150 → $180
May-30-19Upgrade JP Morgan Neutral → Overweight
May-21-19Initiated William Blair Outperform
Oct-29-18Resumed BofA/Merrill Buy $36
Oct-08-18Initiated RBC Capital Mkts Outperform $174
Feb-21-18Initiated William Blair Outperform
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-30-15Reiterated Canaccord Genuity Buy $50 → $58
Oct-13-15Initiated Wells Fargo Outperform
Aug-21-19 10:15PM  Penumbra Inc (PEN) EVP and Chief Business Officer Lynn Rothman Sold $723,300 of Shares GuruFocus.com
Aug-15-19 01:16AM  Penumbra Inc (PEN) Chairman, CEO and President Adam Elsesser Sold $1.2 million of Shares GuruFocus.com
Aug-06-19 10:51PM  Penumbra, Inc. (PEN) Q2 2019 Earnings Call Transcript Motley Fool
06:45PM  Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates Zacks
04:05PM  Penumbra, Inc. Reports Second Quarter 2019 Financial Results PR Newswire
Aug-02-19 11:15PM  Penumbra Inc (PEN) CFO and Head of Strategy Sridhar Kosaraju Sold $846,800 of Shares GuruFocus.com
Aug-01-19 09:15AM  Stocks Advance in July Despite Rate Cut Selloff Zacks
Jul-31-19 01:07PM  Spruce Point: This Stock Could Sink 55% Schaeffer's Investment Research -6.62%
Jul-30-19 10:38AM  Penumbra (PEN) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jul-22-19 07:00AM  Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019 Business Wire
Jul-18-19 09:46AM  Here's Why Investors Should Consider Cerner (CERN) Stock Zacks
Jul-17-19 05:00PM  Penumbra, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference PR Newswire
09:17AM  Henry Schein Closes Acquisition of Elite Computer Italia Zacks
08:51AM  NextGen Inks Deal With Appriss Health, Boosts EHR System Zacks
Jul-16-19 05:00PM  Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 PR Newswire
08:47AM  Intuitive Surgical to Boost da Vinci Platform With Buyout Zacks
08:39AM  Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak Zacks
07:59AM  Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers Zacks
07:45AM  Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand Zacks
Jul-15-19 10:15PM  Penumbra Inc (PEN) Chairman, CEO and President Adam Elsesser Sold $1.4 million of Shares GuruFocus.com
09:12AM  ABT or BIO: Which Stock Has Better Potential Right Now? Zacks
08:33AM  Here's Why You Should Hold Onto Neogen (NEOG) Stock Now Zacks
Jul-12-19 11:49AM  Penumbra, Lovesac, Netflix, NBCUniversal and Amazon highlighted as Zacks Bull and Bear of the Day Zacks
08:54AM  TFX or STE: Which is a Better Investment Pick Right Now? Zacks
06:15AM  Bull of the Day: Penumbra (PEN) Zacks
Jul-11-19 01:22PM  All You Need To Know About Penumbra, Inc.'s (NYSE:PEN) Financial Health Simply Wall St.
11:10AM  Illumina (ILMN) Grows on Innovation & International Growth Zacks
07:19AM  NuVasive (NUVA) Launches Pulse Integrated Technology Platform Zacks
Jul-10-19 11:11AM  Boston Scientific's Global Growth Robust Amid Currency Woe Zacks
08:22AM  Medtronic Releases Positive Results of LATERAL Clinical Trial Zacks
08:10AM  Varian (VAR) Installs ProBeam Compact in Thailand's Hospital Zacks
Jul-09-19 09:38AM  Varian (VAR) to Boost Cancer Treatment With New Partnership Zacks
09:36AM  ResMed (RMD) Rides on Strong SaaS Growth & New Product Suite Zacks
09:30AM  Integra Partners AI-Driven Data Analytics Firm in Wound Care Zacks
08:18AM  Phibro Animal Sees Crucial Progress in ASF Vaccine Development Zacks
07:48AM  Fresenius Set for Global Expansion of Research Activities Zacks
Jul-08-19 10:34AM  Illumina (ILMN) Hits 52-Week High, Can the Run Continue? Zacks
10:29AM  CVS Health Banks on Aetna Prospects, Omnicare May Disappoint Zacks
10:25AM  Boston Scientific to Sell Bead Suit, Make Way for BTG Buyout Zacks
09:00AM  Here's Why CVS Health (CVS) Should Be in Your Portfolio Zacks
Jul-05-19 08:05AM  Here's Why Chemed (CHE) Should Remain in Your Portfolio Now Zacks
07:51AM  Edwards Lifesciences Recalls Heart Device on Balloon Rupture Zacks
Jul-04-19 09:05AM  Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio Zacks
Jul-03-19 09:07AM  Varian to Acquire Boston Scientific's Embolic Bead Products Zacks
Jul-02-19 02:55PM  Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues Zacks
02:45PM  Destiny 2: Penumbra - How To Start The Secret Lumina Exotic Hand Cannon Quest Gamespot Videos
09:15AM  Medtronic's Titan Spine Buyout to Boost Spine Surgery Range Zacks
Jul-01-19 08:36AM  Walgreens Gains on Strategic Deals, Margin Pressure Remains Zacks
08:31AM  Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics Zacks
08:12AM  Here's Why You Should Hold Varian Medical (VAR) Stock Now Zacks
Jun-28-19 09:53AM  Amedisys Rides on New Buyouts, Strength in Personal Care Arm Zacks
08:36AM  Veeva's Vault eTMF Implemented by South Korea's Celltrion Zacks
Jun-27-19 10:25AM  Walgreens Boots (WBA) Q3 Earnings Top Estimates, Margins Dip Zacks
10:18AM  Boston Scientific Strong on Growth Goals and Future Launches Zacks
08:53AM  Varian (VAR) & Tennessee Oncology to Implement Use of Noona Zacks
Jun-26-19 08:06AM  Here's Why You Should Add Bruker (BRKR) to Your Portfolio Zacks
08:04AM  Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now Zacks
08:00AM  Veeva's Submissions & RIM Implemented by Sumitomo Dainippon Zacks
Jun-25-19 08:39AM  Teleflex (TFX) Shares Down on Respiratory Care Product Recall Zacks
08:38AM  Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers Zacks
Jun-24-19 10:37AM  Hill-Rom (HRC) Gains on Product Launch, Prudent Buyouts Zacks
08:24AM  Here's Why You Should Hold GNC Holdings (GNC) Stock for Now Zacks
08:21AM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
08:16AM  Bruker (BRKR) Launches the MALDI Biotyper Sirius System Zacks
Jun-21-19 10:58AM  IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength Zacks
09:37AM  Near-Term Outlook for Medical Instruments Industry Bleak Zacks
08:46AM  Here's Why You Should Add Hologic (HOLX) to Your Portfolio Zacks
08:43AM  Hologic (HOLX) Inks Deal to Acquire SuperSonic Imagine Zacks
Jun-19-19 08:18AM  Haemonetics on a High Owing to Firm Plasma Arm, Global Growth Zacks
08:08AM  Here's Why You Should Invest in Haemonetics (HAE) Stock Now Zacks
Jun-18-19 10:22AM  NuVasive Grows on Strong Product Adoption Amid Pricing Woe Zacks
10:19AM  Haemonetics' Plant Sell-Off to CLS Plasma to be Strategic Fit Zacks
07:42AM  Teleflex (TFX) Hits New 52-Week High on Solid Growth Drivers Zacks
07:27AM  NuVasive Launches Titanium Spine Implant Modulus TLIF-O Zacks
05:59AM  Align (ALGN), Sraumann Cease Talks on iTero Distribution (Revised) Zacks
Jun-17-19 10:10AM  LabCorp Diagnostics Shows Robust Growth Amid Price Declines Zacks
10:07AM  Align (ALGN) Ceases Straumann Distribution Deal, Shares Slip Zacks
07:40AM  Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers Zacks
Jun-14-19 04:41PM  Is Penumbra Inc (PEN) A Good Stock To Buy? Insider Monkey
11:05AM  Moving Average Crossover Alert: Penumbra Zacks
08:51AM  Here's Why You Should Invest in Teleflex (TFX) Stock Now Zacks
08:50AM  Computer Programs and Systems to Offer Microsoft HealthVault Zacks
Jun-13-19 05:42PM  Zimmer Biomet Grows Internationally Despite Pricing Pressure Zacks
10:01AM  Align (ALGN) Introduces Intraoral Scanner, Aids iTero Uptake Zacks
07:59AM  Insulet (PODD) Hits 52-Week High on Solid Growth Prospects Zacks
Jun-12-19 05:22PM  Here's Why You Should Add Cardiovascular Systems (CSII) Stock Zacks
10:01AM  Boston Scientific's New Products, Acquisitions Boost Growth Zacks
09:32AM  Boston Scientific (BSX) Announces Vertiflex Acquisition Zacks
Jun-11-19 04:05PM  Penumbra, Inc. to Present at the BMO 2019 Prescriptions for Success Healthcare Conference PR Newswire
09:53AM  Penumbra said to be considering second-phase project that would bring 1,000 jobs to Roseville American City Business Journals
09:22AM  Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now Zacks
08:39AM  Medtronic Delivers Favorable Outcome on Guardian Connect Zacks
08:37AM  Chemed's VITAS Business Strong, Weak Acuity Mix Shifts a Woe Zacks
Jun-10-19 04:56PM  Why This IBD Stock Of The Day Broke Out Following A Five-Day Sprint Investor's Business Daily
10:23AM  Integra LifeSciences' Organic Growth Strong on New Products Zacks
07:42AM  Tandem Releases Positive Results Of t:slim X2 Pump Studies Zacks
Jun-07-19 10:52AM  Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem Zacks
08:34AM  Varian (VAR) Set to Exhibit ProBeam Proton Therapy System Zacks
08:26AM  DexCom and Companion Medical Collaboration to Support CGM Zacks
Jun-06-19 10:08AM  Walgreens' Weak Market Trends a Woe, Strategic Deals a Boon Zacks
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; and aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the JET, ACE and 3D Revascularization Device brands. It also offers neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands. In addition, the company provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; and detachable embolic coil systems for peripheral embolization under the RUBY Coil brand, as well as microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand. Further, it offers detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand, as well as a complementary device for use with RUBY Coil and POD for vessel occlusion under the POD Packing Coil brand. The company sells its products through direct sales organizations and distributors to hospitals in neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rothman LynnEVP and Chief Business OfficerAug 19Sale144.665,000723,318119,807Aug 21 08:30 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 19Sale144.493,000433,48357,556Aug 21 08:27 PM
Elsesser AdamChairman, CEO and PresidentAug 12Sale149.248,0001,193,9471,082,982Aug 14 07:05 PM
Kosaraju SridharCFO and Head of StrategyAug 01Sale169.365,000846,824166,351Aug 02 08:09 PM
Wilder ThomasDirectorJul 15Sale169.9223740,2713,733Jul 17 07:14 PM
Elsesser AdamChairman, CEO and PresidentJul 11Sale171.848,0001,374,7131,090,982Jul 15 08:23 PM
Kosaraju SridharCFO and Head of StrategyJul 01Sale159.965,000799,802171,351Jul 03 07:30 PM
O'Rourke BridgetDirectorJul 01Sale160.6717528,1173,249Jul 03 07:27 PM
Elsesser AdamChairman, CEO and PresidentJun 11Sale165.088,0001,320,6501,097,982Jun 13 08:26 PM
Kosaraju SridharCFO and Head of StrategyJun 03Sale142.895,000714,461176,351Jun 05 08:37 PM
Elsesser AdamChairman, CEO and PresidentMay 13Sale125.308,0001,002,3991,105,982May 15 07:53 PM
Kosaraju SridharCFO and Head of StrategyMay 02Sale130.044,449578,548182,351May 03 07:22 PM
Kosaraju SridharCFO and Head of StrategyMay 01Sale131.9055172,678186,800May 03 07:22 PM
Elsesser AdamChairman, CEO and PresidentApr 11Sale141.588,0001,132,6171,113,982Apr 15 08:22 PM
Kosaraju SridharCFO and Head of StrategyApr 01Sale143.455,000717,251115,750Apr 03 06:52 PM
Grewal HarpreetDirectorApr 01Sale148.4330445,12313,588Apr 03 06:49 PM
O'Rourke BridgetDirectorApr 01Sale145.7217525,5013,424Apr 03 06:45 PM
Bose AraniChief InnovatorMar 21Sale160.0755,0008,803,850577,191Mar 25 08:26 PM
Elsesser AdamChairman, CEO and PresidentMar 11Sale139.868,0001,118,8436,144Mar 13 06:18 PM
Kosaraju SridharCFO and Head of StrategyMar 11Sale139.845,000699,220120,750Mar 13 06:15 PM
Kassing Don W.DirectorJan 29Sale136.691,086148,4461,577Jan 31 07:44 PM
Grewal HarpreetDirectorJan 03Sale122.0930437,11512,943Jan 04 06:45 PM
Wilder ThomasDirectorJan 02Sale120.5915218,3303,021Jan 04 06:47 PM
Grewal HarpreetDirectorJan 02Sale120.5936243,65413,247Jan 04 06:45 PM
Davis Daniel DonenSee RemarksDec 27Option Exercise4.061,9397,86664,277Dec 31 05:42 PM
O'Rourke BridgetDirectorDec 03Sale142.191,200170,6302,650Dec 06 05:40 PM
Rothman LynnEVP and Chief Business OfficerNov 30Option Exercise3.984,50017,910136,819Apr 15 08:20 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryNov 07Sale150.001,000150,00045,556Nov 09 06:34 PM
Wilder ThomasDirectorOct 02Sale146.9615122,1913,173Oct 04 09:03 PM
Grewal HarpreetDirectorOct 02Sale146.9630344,52913,609Oct 03 08:41 PM
Grewal HarpreetDirectorOct 01Sale149.9436254,27813,912Oct 03 08:41 PM
Davis Daniel DonenSee RemarksSep 11Option Exercise3.988,50033,83066,287Sep 13 08:03 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 30Option Exercise22.042,37152,25718,038Aug 31 08:22 PM
Pray James RobertPresident, InternationalAug 30Sale135.348,1251,099,668485,431Sep 04 08:40 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 30Sale135.102,371320,32215,667Aug 31 08:22 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 29Option Exercise22.0462913,86316,296Aug 31 08:22 PM
Evans Robert D.EVP, Gen. Counsel & SecretaryAug 29Sale135.0062984,91515,667Aug 31 08:22 PM
Grewal HarpreetDirectorAug 27Sale129.331,528197,62414,274Aug 29 08:59 PM
Pray James RobertPresident, InternationalAug 27Sale130.385,925772,505493,556Aug 29 08:54 PM
Davis Daniel DonenSee RemarksAug 27Sale130.387,500977,82557,787Aug 29 08:32 PM
Pray James RobertPresident, InternationalAug 23Sale130.272,200286,594499,481Aug 27 08:48 PM